Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Spotify Technology (SPOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Spotify Technology — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.03 (market cap $3.94B), while Spotify Technology trades at $519.85 (market cap $108.44B). The key difference: Spotify Technology is far larger — about 27.5× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Spotify Technology nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Spotify Technology for 111 Days on average.
| EWTX | SPOT | |
|---|---|---|
Market Cap | $3.94B | $108.44B |
Volume | 810,104 | 1,252,448 |
Sector | Health | Media |
52-Week High | $48.35 | $689.21 |
52-Week Low | $14.89 | $412.75 |
Typical Hold Time | 0 Days | 111 Days |
Enterprise Value | $3.48B | $98.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Spotify (SPOT) trades at $523.96, down 0.92% on the day, as the stock consolidates near key technical support levels. The company demonstrates strong fundamental momentum with revenue growth accelerating to $17.19 billion in 2025 and net income surging to $2.21 billion, representing a 12.87% margin. Recent earnings show mixed results with Q2 2026 missing expectations, but analyst sentiment remains overwhelmingly positive with 62% buy ratings and a $588 consensus price target suggesting 12% upside potential.
The outlook remains favorable given Spotify's expanding gross margins and robust cash flow generation, though investors should monitor competitive pressures in streaming and potential market volatility. With technical indicators showing bullish moving average alignment and strong institutional support, the stock appears positioned for continued growth pending Q3 2026 earnings results expected October 22, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →
